Skip to main content

and
  1. Article

    Open Access

    COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

    Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to Coronavirus disease 2019 (COVID-19) due to age, disease, and treatment-related immunosuppression. We aimed to assess risk factors of ...

    Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò in Leukemia (2021)

  2. Article

    COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

    Chronic lymphocytic leukemia (CLL) is a disease of the elderly, characterized by immunodeficiency. Hence, patients with CLL might be considered more susceptible to severe complications from COVID-19. We undert...

    Lydia Scarfò, Thomas Chatzikonstantinou, Gian Matteo Rigolin, Giulia Quaresmini in Leukemia (2020)